Feb 24, 2022, 01:00 AM by User Not Found

Bio-IT World | In the opening plenary panel for the Molecular and Precision Med Tri-Con this week, Robert Green, Brigham and Women’s Hospital, led a group in exploring how genomics, digital health, and more will converge to deliver precision health. He was joined by Megan Mahoney, Stanford University; Jessica Mega, Verily Life Sciences; Sir Mark Caulfield, Barts Life Sciences & Queen Mary University of London; and Lara Jehi, Cleveland Clinic.

Feb 23, 2022, 01:00 AM by User Not Found

Bio-IT World | At this week’s Molecular & Precision Medicine Tri-Con event, Simon Gregory, profession or neurology at the Duke University School of Medicine, outlined how his team has been using 10X Genomics’ Visium platform and Oxford Nanopore long read sequencing to understand the pathology of Alzheimer’s Disease development.

Feb 23, 2022, 01:00 AM by User Not Found

Bio-IT World | On the first morning of the Molecular & Precision Med Tri-Con event, Viktor Adalsteinsson, associate director of the Gerstner Center for Cancer Diagnostics at the Broad Institute, explored new tools and techniques for detecting minimal residual disease.

Feb 22, 2022, 15:27 PM by User Not Found

Bio-IT World | Bio-IT World and BioTeam have been exploring the drivers of life sciences innovation for years during the Bio-IT World Conference & Expo and in regular columns in the publication. Now, together, we’ve launched a new podcast to capture in-depth conversations with leaders in the field about data, culture, technology, and more.

Feb 18, 2022, 17:24 PM by

Feb 18, 2022, 17:24 PM by

Feb 18, 2022, 17:24 PM by

Bracknell, UK – 14th February 2022: mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of its major growth and success, without significant external investment.

Feb 18, 2022, 17:24 PM by

mdgroup Appoints Steph Katz as Director of Seacole Health Combining Passion for Nursing and Clinical Research to Provide Remarkable Patient Experiences Bracknell, UK: 15 February 2022 - mdgroup, the leading global provider of personalised clinical study services, has appointed Steph Katz as Director of business subsidiary Seacole Health. Seacole Health brings mdgroup’s mobile health and clinical research staff resourcing under one roof. Steph is the ideal person to lead this exciting new venture because of her wealth of healthcare knowledge. Having started as an oncology nurse in intensive care units, Steph achieved her MSN in Nursing Education and began training research coordinators, clinical nurses and fellows. She then took on a management role, helping to develop and operationalize institutional, federal and commercial clinical research projects before pursuing an MBA.

Feb 18, 2022, 17:24 PM by

AI-powered cloud software platform PubHive Navigator now features a new user dashboard that speeds up systematic literature review workflows for PubHive users

Feb 18, 2022, 17:24 PM by

Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.

Feb 18, 2022, 17:24 PM by

Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures

Feb 18, 2022, 17:24 PM by

Watson-Marlow Fluid Technology Group (WMFTG) is extending its industrial Ethernet control offer by making PROFINET available on its 530, 630 and 730 series of cased peristaltic pumps. This additional communication capability allows customers to access fast, accurate performance data and seamless connectivity with modern PLC control systems and the Internet of Things (IoT) using either EtherNet/IP™ or PROFINET®.

Feb 18, 2022, 17:24 PM by

Researchers at the University of Miami have unveiled a groundbreaking research project called the MILBox, which uses AI to create “digital twins” of patients. Once created, healthcare practitioners can test and evaluate various treatment options and potential outcomes on these “digital twins,” before applying them in the physical world. The study is supported by Amazon Web Services and Open Health Network, which use data from wearables and in-home sensors to create these “digital twins."

Feb 18, 2022, 17:24 PM by

Feb 18, 2022, 13:48 PM by User Not Found

Bio-IT World | All industries drive innovation. The pharmaceutical industry is no different — except that their innovations improve or save lives. The clinical trial process is an important activity that any drug or medical device company works with daily. This is often a target for innovations so that they can improve activities within the trial process. For years, the industry has been dominated by SAS software for its statistical and clinical reporting. Organizations are now actively starting to use other technologies with the R language being heavily adopted.

Feb 17, 2022, 01:00 AM by User Not Found

Bio-IT World | The Pistoia Alliance launched a new project on the microbiome yesterday, which could help speed up the advancement of new, precision medicines and treatments. The project is funded by Bayer, BMS, Eagle Genomics, Pfizer, Roche and Takeda and aims to incorporate microbiome data into the drug development pipeline by gathering all existing microbiome data to create a global standardized ‘atlas’ that scientists can refer to when choosing new drug candidates.

Feb 15, 2022, 01:00 AM by User Not Found

Bio-IT World | In December the National Institutes of Health (NIH) released the latest version if its Sleep Research Plan that used a crowdsourcing campaign to ensure all willing voices on the topic were captured. The congressionally-mandated plan, the fourth in a series published since 1996, seeks to draw the attention of investigators to high-priority areas that could “make an impact within the next five to 10 years,” according to Marishka K. Brown, Ph.D., director of the National Center on Sleep Disorders Research (NCSDR).

Feb 14, 2022, 10:08 AM by User Not Found

Bio-IT World |The Genome in a Bottle (GIAB) Consortium has just reported a new, expanded benchmark for 273 medically relevant genes that are challenging to clinically assess with current sequencing methods. The work is published in Nature Biotechnology.

Feb 10, 2022, 14:06 PM by

Université de Paris has installed new Bruker In Vitro Diagnostic research (IVDr) nuclear magnetic resonance (NMR) spectrometer within its MetaboParis-Santé platform located in the center of Paris city, France.

Feb 10, 2022, 14:06 PM by

Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, and Domainex Ltd., today announce a collaboration focused on developing small molecule therapies targeting neuroinflammation that could slow the progression of Parkinson’s.